Rigel PharmaceuticalsRIGL
13F holders, Q4 2025 (December 31)10holders +4
5new positions
1sold out
$42.83avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding Rigel Pharmaceuticals Inc. (RIGL) in their 13F filings, up 4 from Q3 2025. 5 opened new positions and 1 sold out. The largest holders were Advisory Services Network, LLC ($1.9M), Hughes Financial Services, LLC ($43K) and Farther Finance Advisors, LLC ($33K).
- Company
- Rigel Pharmaceuticals Inc.
- CUSIP
- 766559603
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $56K |
| Exits | 1 | $4K |
All 13F filers, Q3 2025 → Q4 2025: 13,307 shares bought and 124 shares sold, net +13,183 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Advisory Services Network, LLC | 0.03% | Add +37.7% | 43,666 | $1.9M |
| Hughes Financial Services, LLC | 0.01% | New | 1,001 | $43K |
| Farther Finance Advisors, LLC | 0.00% | Add +5.8% | 772 | $33K |
| Versant Capital Management, Inc | 0.00% | No change | 224 | $10K |
| Triumph Capital Management | 0.00% | New | 200 | $9K |
| Parallel Advisors, LLC | 0.00% | New | 77 | $3K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 27 | $1K |
| Essential Partners LLC | 0.00% | Add +233.3% | 10 | $428 |
| Rothschild Investment LLC | 0.00% | New | 8 | $343 |
| Huntington National Bank | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is RIGL's weight in each manager's 13F, not the share of Rigel Pharmaceuticals Inc. the manager owns.